Figure 3.
Survival outcomes of IDHmut AML in the total study cohort based on IDH isoform and mutation subtype. There was no difference between isoform IDH1 vs IDH2 for (A) EFS or (B) OS. Similarly, there was no difference in outcomes according to mutation subtype IDH1R132 vs IDH2R140 vs IDH2R172 for (C) EFS or (D) OS. P values calculated by log-rank test.

Survival outcomes of IDHmut AML in the total study cohort based on IDH isoform and mutation subtype. There was no difference between isoform IDH1 vs IDH2 for (A) EFS or (B) OS. Similarly, there was no difference in outcomes according to mutation subtype IDH1R132 vs IDH2R140 vs IDH2R172 for (C) EFS or (D) OS. P values calculated by log-rank test.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal